FDA

Georgia congress members question FDA's solution to cancer drug shortage
WUGA.org
Wed, 08/30/23 - 09:50 am
drug shortages
cancer
Georgia
FDA
Hopes dim for Medtronic hypertension treatment after FDA panel rebuff
Medtech Dive
Tue, 08/29/23 - 11:20 am
Medtronic
Medtech
hypertension
devices
FDA
Symplicity Spyral
FDA Decisions 2023: Sandoz, Gilead Sciences and More
BioSpace
Fri, 08/25/23 - 11:31 am
FDA
Sandoz
Novartis
Gilead Sciences
Pfizer
Neurocrine
Regeneron
Ipsen
Revance Therapeutics
Delcath Systems
Janssen
Galera Therapeutics
Biogen
Roche
Mesoblast
Taiho Oncology
FDA Approves Sandoz Biosimilar to Biogen’s MS Therapy Tysabri
BioSpace
Fri, 08/25/23 - 09:53 am
Biogen
Sandoz
FDA
biosimilars
MS
multiple sclerosis
Tysabri
Evaluating renal denervation rivals, FDA advisory panel backs ReCor, shuns Medtronic
Fierce Biotech
Fri, 08/25/23 - 09:51 am
Medtech
FDA
renal denervation
Otsuka
Recor
Medtronic
hypertension
Alentis’ ALE.C04 receives fast track designation from FDA
Pharmaceutical Business Review
Fri, 08/25/23 - 09:44 am
Alentis Therapeutics
FDA
ALE.C04
metastatic head and neck squamous cell carcinoma
head and neck cancer
Medtronic pleased with Diabetes progress as new CGM’s FDA review ‘is progressing’
Mass Device
Wed, 08/23/23 - 09:59 am
Medtronic
Medtech
diabetes
FDA
continuous glucose monitoring
MiniMed 780G
Look out, Teva. Neurocrine's Ingrezza wins Huntington's disease FDA nod to rival Austedo
Fierce Pharma
Wed, 08/23/23 - 09:48 am
Neurocrine
Ingrezza
FDA
Huntington's disease
Teva Pharmaceutical
FDA greenlights medical device to combat bladder issues
Stat
Tue, 08/22/23 - 11:29 pm
Medtech
overactive bladder
BlueWind Medical
FDA
devices
Behind the FDA Submission: How J&J Won a Key Approval in AF Ablation
Medical Devices and Diagnostics Industry
Tue, 08/22/23 - 09:56 am
JNJ
Medtech
Biosense Webster
FDA
cardiac ablation
New Warning Letter Reflects Recent Shifts in FDA Enforcement of Drug Promotion
Sidley Austin LLP
Tue, 08/22/23 - 09:53 am
FDA
drug marketing
pharma marketing
OPDP
warning letters
Nascent Biotech to Begin Phase II Clinical Trials for Brain Cancer
BioSpace
Tue, 08/22/23 - 09:44 am
Nascent Biotech
FDA
clinical trials
brain cancer
monoclonal antibodies
FDA approves Pfizer’s RSV vaccine for use in pregnancy
BioPharma Dive
Mon, 08/21/23 - 08:02 pm
Pfizer
RSV
vaccines
infants
FDA
Abrysvo
pregnancy
KRAS crisis? FDA will gather advisers to weigh full approval for Amgen's Lumakras
Fierce Pharma
Mon, 08/21/23 - 06:56 pm
Amgen
Lumakras
KRAS inhibitors
FDA
Regeneron Expands Eylea’s Label with High-Dose Approval
BioSpace
Mon, 08/21/23 - 10:44 am
Regeneron
Eylea
FDA
Regeneron’s Antibody Gets FDA Approval for Ultra-Rare Hereditary Disease
BioSpace
Sun, 08/20/23 - 05:17 pm
Regeneron
FDA
CHAPLE disease
Veopoz
FDA Approves Ipsen’s Palovarotene for Ultra-Rare Bone Disease
BioSpace
Thu, 08/17/23 - 10:08 am
Ipsen
palovarotene
FDA
Sohonos
fibrodysplasia ossificans progressiva
FDA Hits Integra with Warning Letter
Medical Devices and Diagnostics Industry
Thu, 08/17/23 - 10:00 am
Integra LifeSciences
Boston
FDA
device manufacturing
Medtech
FDA starts speedy review of Servier's Tibsovo in MDS
Pharmaphorum
Thu, 08/17/23 - 09:58 am
Servier
IDH inhibitors
MDS
Tibsovo
FDA
priority reviews
Medtronic’s dialysis device recall assigned to Class I by the FDA
Medtech Dive
Thu, 08/17/23 - 09:57 am
Medtech
Medtronic
FDA
device recalls
hemodialysis

Pages